Showing results (11-20 of 147) with videos related to
Sort By:
Pageof 15
Current Treatment Options in Oncology|December 14, 2005
Second- and third-line treatments in non-small cell lung cancerAtul Kumar, Heather WakeleeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2009
Antiangiogenic agents and vascular disrupting agents for the treatment of lung cancer: a reviewChristelle Clément-Duchêne, Heather WakeleeDrugs of Today (Barcelona, Spain : 1998)|January 13, 2009
Pemetrexed disodium for the treatment of NSCLC: an updateJerry Y Hsu, Heather WakeleeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung CancerYoungtae Jeong, Jessica A Hellyer, Henning Stehr, et al.Biologics : Targets & Therapy|August 27, 2009
Review of erlotinib in the treatment of advanced non-small cell lung cancerKristen N Ganjoo, Heather WakeleeAdvances in Experimental Medicine and Biology|December 16, 2015
Lung Cancer in Never SmokersGabriel Alberto Rivera, Heather WakeleeThe Oncologist|December 22, 2005
Optimizing first-line treatment options for patients with advanced NSCLCHeather Wakelee, Chandra P BelaniCurrent Treatment Options in Oncology|July 1, 2020
Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of ImmunotherapyMeera Ragavan, Millie DasClinical Lung Cancer|July 15, 2011
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancerMillie Das, Jessica S Donington, James Murphy, et al.Current Treatment Options in Oncology|July 28, 2012
Treatment of leptomeningeal spread of NSCLC: a continuing challengeSeema Nagpal, Jonathan Riess, Heather WakeleePageof 15